Latest News

History of depression, stress tied to Alzheimer’s, MCI risk


 

TOPLINE:

People with a history of depression or stress were significantly more likely to be diagnosed with mild cognitive impairment (MCI) or Alzheimer’s disease (AD) later in life compared with those without either condition, a new study found.

METHODOLOGY:

  • Longitudinal cohort study of 1,362,548 people with records in the Region Stockholm administrative health care database with a diagnosis of stress-induced exhaustion disorder (SED), depression, or both between 2012 and 2013.
  • Cohort followed for diagnosis of MCI or AD between 2014 and 2022.

TAKEAWAY:

  • SED diagnosed in 0.3%, depression in 2.9% and both SED and depression in 0.1%
  • Compared with people without SED or depression, AD risk was more than double in patients with SED (adjusted odds ratio [aOR], 2.45; 99% confidence interval [CI], 1.22-4.91) or depression (aOR, 2.32; 99% CI, 1.85-2.90) and four times higher in patients with both SED and depression (aOR, 4.00; 99% CI, 1.67-9.58)
  • Risk for MCI was also higher in people with SED (aOR, 1.87; 99% CI,1.20-2.91), depression (aOR, 2.85; 99% CI, 2.53-3.22) or both SED and depression (aOR, 3.87; 99% CI, 2.39-6.27) vs patients with no history of SED or depression.
  • Only patients with depression had a higher risk for another dementia type (aOR, 2.39; 99% CI, 1.92-2.96).

IN PRACTICE:

“Future studies should examine the possibility that symptoms of depression and/or chronic stress could be prodromal symptoms of dementia rather than risk factors,” study authors wrote.

SOURCE:

The study was conducted by Johanna Wallensten, doctoral student, department of clinical sciences, Danderyd Hospital, Stockholm, and colleagues and funded by the Karolinska Institute. It was published online in Alzheimer’s Research and Therapy.

LIMITATIONS:

Use of a health care registry could have led to over- or underestimation of depression, MCI and AD. The study probably captures most people with depression but not most people with depressive symptoms.

DISCLOSURES:

The authors reported no relevant conflicts.

A version of this article appeared on Medscape.com.

Recommended Reading

Most with early AD not eligible for new antiamyloid drugs
MDedge Family Medicine
Dementia diagnosis a good time to reduce polypharmacy
MDedge Family Medicine
Abdominal fat linked to lower brain volume in midlife
MDedge Family Medicine
Sedentary lifestyle tied to increased dementia risk
MDedge Family Medicine
How does lecanemab work in Alzheimer’s?
MDedge Family Medicine
AHA reviews impact of aggressive LDL lowering on the brain
MDedge Family Medicine
Unique twin study sheds new light on TBI and risk of cognitive decline
MDedge Family Medicine
Multivitamins and dementia: Untangling the COSMOS study web
MDedge Family Medicine
Loneliness tied to increased risk for Parkinson’s disease
MDedge Family Medicine
Do new Alzheimer’s drugs get us closer to solving the Alzheimer’s disease riddle?
MDedge Family Medicine